MAP4343
CAS: 511-26-2
Ref. 3D-AAA51126
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Informação sobre produto
- (3β)-3-Methoxypregn-5-en-20-one
- 3β-Methoxy-5-pregnen-20-one
- L 542856-0
- Map 4343
- NSC 31617
- Pregn-5-en-20-one, 3-methoxy-, (3.beta.)-
- Pregn-5-en-20-one, 3-methoxy-, (3β)-
- Pregn-5-en-20-one, 3.beta.-methoxy-
- Pregn-5-en-20-one, 3β-methoxy-
- Pregnenolone 3-methyl ether
- Ver mais sinónimos
- Pregnenolone methyl ether
MAP4343 is a peptide that has been shown to activate the ERK1/2 and JNK pathways. MAP4343 has also been shown to bind to the TGF-β receptor, which is a receptor tyrosine kinase that regulates cell proliferation, differentiation, and apoptosis. The ligand for this receptor is Transforming Growth Factor beta 1 (TGF-β1). MAP4343 can be used as a research tool for studying protein interactions and receptors.
MAP4343 is an inhibitor of Ion channels, such as voltage-gated potassium channels. It can inhibit ion channel currents in Xenopus oocytes expressing human potassium channels by binding to the extracellular domain of these channels. This inhibition leads to a decrease in the membrane potential.
Propriedades químicas
Consulta técnica sobre: 3D-AAA51126 MAP4343
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
